Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain

scientific article published on 29 January 2009

Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1254/JPHS.08R29FM
P698PubMed publication ID19179803

P2093author name stringAkihiko Takashima
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)174-178
P577publication date2009-01-29
P1433published inJournal of Pharmacological SciencesQ15766064
P1476titleDrug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain
P478volume109

Reverse relations

cites work (P2860)
Q90191974A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth
Q30485018Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
Q34286579AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease
Q60921224Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β
Q30408186Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.
Q36444079Glycogen Synthase Kinase 3β-mediated Phosphorylation in the Most C-terminal Region of Protein Interacting with C Kinase 1 (PICK1) Regulates the Binding of PICK1 to Glutamate Receptor Subunit GluA2
Q39728463Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment
Q42689688Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease
Q38023551Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.
Q47736903Learning ability is a key outcome determinant of GSK-3 inhibition on visuospatial memory in rats
Q39639654Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis
Q36128825Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models

Search more.